Litifilimab
Based on 1 Customer Validation
Litifilimab (BIIB059) is a humanized IgG1 monoclonal antibody targeting BDCA2. Litifilimab induces internalization of BDCA2 receptors on the membrane of plasmacytoid dendritic cells, inhibits the TLR7/TLR9 signaling pathway, and suppresses the production of type I interferons. Litifilimab can be used in the research of systemic and cutaneous lupus erythematosus.
For research use only. We do not sell to patients.
- Purity : 99.51%
- CAS No.: 2407378-48-5
- Molecular Weight:146.6 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
|
BDCA2 |
Dectin-1 |
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized CLEC4C Protein, Human can bind Litifilimab. The EC50 for this effect is 19.73 ng/mL.
Product Details
-
CAS No. 2407378-48-5
-
Accession Q8WTT0
-
Synonyms BIIB059
-
Molecular Weight 146.6 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
99.51%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
References
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Regulation of Type I Interferon in the Prevention and Treatment of Viral and Inflammatory Diseases
Regulation of type I interferon in the prevention and treatment of viral and inflammatory diseases refers to the control of interferon-α and interferon-β production, signaling, and biological activity to balance antiviral defense with immune homeostasis.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)